<DOC>
	<DOCNO>NCT00311129</DOCNO>
	<brief_summary>The purpose study assess antitumor effect safety fludarabine phosphate tablet combination rituximab patient indolent lymphoma .</brief_summary>
	<brief_title>Efficacy Safety Study SH T 586 Combination With Rituximab Treat Low-Grade NHL</brief_title>
	<detailed_description>As 29 May 2009 , clinical trial sponsor Genzyme Corporation . NOTE : This study originally post sponsor Schering AG , Germany , subsequently rename Bayer Schering Pharma AG , Germany .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Vidarabine</mesh_term>
	<criteria>Patients CD 20 positive , relapsed/refractory indolent lymphoma . ( Regimens prior chemotherapy limit 2 ; prior rituximab treatment 16 time allow . ) Patients measurable lesion ( &gt; 1.5 cm ) . Patients receive treatment 4 week complete previous therapy ( 6 month case antibody therapy ) . ECOG performance status : 0 1 Patients adequately maintain organ function . Patients infectious disease , serious complication , serious gastrointestinal symptom , serious bleeding tendency , serious CNS symptom , fever &lt; /=38 Â°C , interstitial pneumonia pulmonary fibrosis , active malignancy , autoimmune hemolytic anemia history disease , glaucoma . Patients positive HBs antigen , HCV antibody , HIV antibody . Patients receive GCSF transfusion within 1 week registration . Patients history allergy purine nucleoside analogue . Patients experience serious hypersensitivity anaphylaxis rituximab mouse proteinderived product . Patients ever receive prior therapy fludarabine phosphate injection , pentostatin , cladribine , SH T 586 , blood stem cell transplant , monoclonal antibody therapy rituximab NHL ( include radioimmunotherapy ) . Patients progressive disease within 6 month receive therapy include rituximab . Women pregnant , childbearing potential , lactate . Patients agree practice contraception .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>